MIRAMOUNT BEHAVIORAL HEALTH
1. Target Overview & Investment Thesis
MIRAMOUNT BEHAVIORAL HEALTH is a 72-bed safety-net/medicaid heavy in nan, WI with $9.3M in net patient revenue and a -21.8% operating margin. The hospital serves a payer mix of 15.0% Medicare, 51.1% Medicaid, and 33.9% commercial.
Thesis: Turnaround. Our ML models identify $695K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -21.8% to -14.4% (+743bps).
| Net Revenue HCRIS | $9.3M |
| Current EBITDA COMPUTED | $-2.0M |
| Operating Margin COMPUTED | -21.8% |
| Occupancy HCRIS | 21.8% |
| Revenue / Bed COMPUTED | $130K |
| Net-to-Gross HCRIS | 56.9% |
| Distress Probability ML | 69.3% |
2. Market Context & Competitive Position
WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -21.8% places it below the state median. Among 47 size-comparable peers (36-144 beds), the median margin is -4.8%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (36-144), prioritizing same-state peers. 47 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MIRAMOUNT BEHAVIORAL HEALTH (Target) | WI | 72 | $9.3M | -21.8% |
| ST. JOSEPHS COMM. HOSPT. | WI | 70 | $436.8M | 66.1% |
| MCHS FRANCISCAN HEALTHCARE IN | WI | 103 | $413.8M | -7.2% |
| AURORA MEDICAL CENTER GRAFTON | WI | 132 | $300.4M | 16.7% |
| ST. AGNES HOSPITAL | WI | 77 | $275.9M | -3.0% |
| BELOIT MEMORIAL HOSPITAL INC. | WI | 97 | $249.6M | -3.0% |
| THEDACARE REGIONAL MEDICAL CEN | WI | 139 | $247.3M | 5.1% |
| AURORA MEDICAL CENTER OF OSHKO | WI | 79 | $222.3M | 17.9% |
| MARSHFIELD MEDICAL CENTER-EAU | WI | 56 | $214.6M | -21.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $695K (743bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $196K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $188K | +201bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $187K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $114K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +10bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-2.0M |
| + RCM Uplift | +$695K |
| Pro Forma EBITDA | $-1.3M |
| Current Margin | -21.8% |
| Pro Forma Margin | -14.4% |
| WC Released (1x) | $358K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-3.1M | $-6.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-3.1M | $-8.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-2.8M | $-6.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-2.8M | $-8.3M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-3.4M | $-9.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-3.4M | $-11.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (51.1%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Medium | Low occupancy | At 21.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 69.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 47 hospitals with 36-144 beds
- Same-state prioritization (n=48)
- Comp margins: P25=-16.2% / P50=-4.8% / P75=11.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.